- Hem
- Böcker
- Kurslitteratur
- Vård, Omsorg & Medicin
- Cancer Clinical Trials (häftad, eng)
Cancer Clinical Trials (häftad, eng)
The controlled clinical trial has become an essential part of the clinician''s decision-making process. Clinical trials, however, still rais...
575 kr
Bara 2 kvar
Skickas inom 2-3 vardagar
- Fri frakt
Fri frakt över 299:-
Snabb leverans
Alltid låga priser
Produktbeskrivning
The controlled clinical trial has become an essential part of the clinician''s decision-making process. Clinical trials, however, still raise methodological problems that are important and at the same time controversial: subgroup analysis and interactions, meta-analy sis of similar trials, consideration of subjective clinical opinions and those of the public at large, assessment of quality of life, pre vention trials, and so on.
In February 1987 we took our third step along the road to evaluating these issues in dialogues between cli nicians, psychologists, legal experts, and statisticians. The talks presented at the meeting were revised by the authors afterwards and have been rearranged by the editors to form a strictly organ 1 2 ized book.
The two preceding meetings in 1978 and 1981 focused strongly on adjuvant therapy in primary breast cancer, but this top ic served merely as a nucleus in the third meeting. This meeting, although called the Third Heidelberg Symposium was forced to leave Heidelberg and in fact was held in Freiburg.
Without the interest and enthusiasm of Professor Martin Schu macher and his colleagues in Freiburg the meeting would never have taken place. The meeting was generously supported again by the Federal Ministry of Research and Technology (Bundesministe rium flir Forschung und Technologie, BMFT) within the framework of the West German BMFT Breast Cancer Study Group.
We are grateful, in particular, to Mr. Hans W. Herzog for his personal in volvement. Juni 1988 H. Scheurlen, R. Kay, M.
In February 1987 we took our third step along the road to evaluating these issues in dialogues between cli nicians, psychologists, legal experts, and statisticians. The talks presented at the meeting were revised by the authors afterwards and have been rearranged by the editors to form a strictly organ 1 2 ized book.
The two preceding meetings in 1978 and 1981 focused strongly on adjuvant therapy in primary breast cancer, but this top ic served merely as a nucleus in the third meeting. This meeting, although called the Third Heidelberg Symposium was forced to leave Heidelberg and in fact was held in Freiburg.
Without the interest and enthusiasm of Professor Martin Schu macher and his colleagues in Freiburg the meeting would never have taken place. The meeting was generously supported again by the Federal Ministry of Research and Technology (Bundesministe rium flir Forschung und Technologie, BMFT) within the framework of the West German BMFT Breast Cancer Study Group.
We are grateful, in particular, to Mr. Hans W. Herzog for his personal in volvement. Juni 1988 H. Scheurlen, R. Kay, M.
| Format | Häftad |
| Omfång | 272 sidor |
| Språk | Engelska |
| Förlag | Springer-Verlag Berlin and Heidelberg GmbH & Co. KG |
| Utgivningsdatum | 2011-12-27 |
| ISBN | 9783642834219 |
Specifikation
Böcker
- Häftad, 272, Engelska, Springer-Verlag Berlin and Heidelberg GmbH & Co. KG, 2011-12-27, 9783642834219
Leverans
Vi erbjuder flera smidiga leveransalternativ beroende på ditt postnummer, såsom Budbee Box, Early Bird, Instabox och DB Schenker. Vid köp över 299 kr är leveransen kostnadsfri, annars tillkommer en fraktavgift från 29 kr. Välj det alternativ som passar dig bäst för en bekväm leverans.
Betalning
Du kan betala tryggt och enkelt via Avarda med flera alternativ: Swish för snabb betalning, kortbetalning med VISA eller MasterCard, faktura med 30 dagars betalningstid, eller konto för flexibel delbetalning.
Specifikation
Böcker
- Format Häftad
- Antal sidor 272
- Språk Engelska
- Förlag Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
- Utgivningsdatum 2011-12-27
- ISBN 9783642834219